CDC Emergency Meeting to Discuss Myocarditis Reviews in Adolescents Following COVID Vaccination • Protecting Children’s Health


The Centers for Disease Control and Prevent’s Advisory Committee on Immunization Practices will hold an emergency meeting tomorrow, Friday, June 18 beginning at 11 am ET to discuss the potential benefit risk of COVID mRNA vaccines in adolescents and young adults. on following a much higher than expected number of reports of cardiac inflammation following vaccines.

Defender experienced censorship on many social channels. Be sure to keep in touch with news that matters subscribe to our top news of the day. It’s free.

The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) will create a emergency meeting tomorrow, Friday, June 18, beginning at 11 am ET. to discuss the potential benefit of COVID mRNA vaccines in adolescents and adults.

The meeting was Office has partnered last week after the CDC recognized a much higher expected number of reports of heart inflammation in young people after they receive a Pfizer or Modern VACCINE

Sign up to watch the livestream of the ACIP emergency meeting, including live commentary by Dr. Meryl Nass.

During a June 10 U.S. Food and Drug Administration (FDA) hearing to figure out what data the agency needs to expand Emergency Use Permit of COVID vaccines for children under 12, CDC revealed that it is aware of the total 475 cases in myocarditis or pericarditis in patients 30 and older.

The CDC identified 226 reports that the agency’s “working case definition” could be met in myocarditis and pericarditis following the outbreaks.

Tom Shimabukuro, deputy director of the CDC’s Immunization Safety Office, said during the meeting there was a higher than expected number of cases of heart inflammation in young people recently vaccinated with their second dose of mRNA vaccine.

CDC data is displayed There were 196 reports of myocarditis and pericarditis among those aged 18 to 24 years to May 31, compared with the expected rate of between eight and 83 cases.

Among 16- to 17-year-olds, 79 cases of myocarditis and pericarditis were reported as of May 31. The expected rate of people in this age group is between two and 19 cases, according to Shimabukuro in his presentations.

Shimabukuro SAYS the CDC finds “mostly always” there have been reports of rare cases of heart inflammation in the past studying Israel and reports at the U.S. Department of Defense earlier this year.

This week, The Defender reports of a 19-year-old college freshman who died of complications from a heart transplant following myocarditis following his second dose of the Moderna vaccine.

The Protector too reports this week a 21-year-old student was being treated for myocarditis, after receiving a second dose of Moderna’s vaccine.

Based on the latest data from the CDC’s Vaccine Adverse Events Reporting System (VAERS), there are 900 cases of myocarditis and pericarditis, among all age groups reported in the U.S. following COVID vaccination between Dec.14, 2020 and June 4, 2021. Of the 900 cases reported, 533 cases dedicated to Pfizer, 331 cases in Moderna and 32 cases on the COVID vaccine by J&J.

Last month, the U.S. Food and Drug Administration (FDA) expanded Pfizer Emergency Use (EUA) to include 12- to 15-year-olds, who are currently receiving vaccines. Last week Moderna submitted us aka application with the FDA for EUA approval of its vaccine for 12- to 17-year-olds.

The FDA has received three separate petitions – Protecting the Health of Children, The Consent Action Network announced and a group of 27 renowned health experts and scientists – Requests the agency to ban COVID vaccines for children, or suspend all use of vaccines until further safety studies are completed.

Sign up to watch the livestream of the ACIP emergency meeting, including live commentary by Dr. Meryl Nass.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *